Contraindications of atorvastatin
Pro Research Analysisby 
Searched over 200M research papers
Contraindications of Atorvastatin
Overview of Atorvastatin Safety
Atorvastatin is a widely used statin for managing cholesterol levels and preventing cardiovascular events. It is generally well-tolerated across various dosages, ranging from 10 mg to 80 mg per day 123. However, certain contraindications and adverse effects must be considered to ensure patient safety.
Hepatic Contraindications
Liver Function Abnormalities
One of the primary concerns with atorvastatin is its potential impact on liver function. Persistent elevations in hepatic transaminases, which are enzymes indicative of liver damage, have been observed in a small percentage of patients. Specifically, 0.5% of patients experienced elevations greater than three times the upper limit of normal (ULN) . Another study reported similar findings, with 0.1% to 0.6% of patients showing elevated hepatic transaminases depending on the dosage . These elevations are generally rare but warrant regular monitoring of liver function tests during treatment.
Musculoskeletal Contraindications
Myopathy and Rhabdomyolysis
Muscle-related side effects, such as myopathy and rhabdomyolysis, are significant concerns with statin therapy. However, the incidence of these conditions with atorvastatin is relatively low. In a comprehensive analysis, treatment-associated myalgia was reported in 1.9% of patients, with no cases of rhabdomyolysis or myopathy . Another study corroborated these findings, showing myalgia in 1.4% to 1.5% of patients, depending on the dose, and no cases of rhabdomyolysis . Despite the low incidence, patients should be advised to report any unexplained muscle pain or weakness.
Metabolic Contraindications
Insulin Resistance and Diabetes
Recent studies have indicated that atorvastatin may adversely affect glucose metabolism. Atorvastatin has been shown to increase fasting plasma insulin and glycated hemoglobin levels, which are markers of insulin resistance and ambient glycemia . This effect was observed across various dosages, suggesting that atorvastatin can potentially increase the risk of developing diabetes, particularly in hypercholesterolemic patients.
Pediatric Considerations
Safety in Children and Adolescents
Atorvastatin has also been studied in pediatric populations with familial hypercholesterolemia or severe hyperlipidemia. The drug was found to be effective and well-tolerated in children and adolescents, with significant reductions in LDL cholesterol and other lipid parameters . However, the long-term safety profile in this population requires further investigation.
Conclusion
While atorvastatin is generally safe and effective for managing cholesterol levels, it is essential to consider its contraindications. Regular monitoring of liver function and muscle symptoms is crucial, and caution should be exercised in patients at risk of diabetes. Understanding these contraindications can help optimize treatment and ensure patient safety.
Sources and full results
Most relevant research papers on this topic
Multiple‐dose pharmacokinetics, pharmacodynamics, and safety of atorvastatin, an inhibitor of HMG‐CoA reductase, in healthy subjects
Atorvastatin doses of up to 80 mg/day were well tolerated and had significant cholesterol-lowering effects in healthy subjects.
Atorvastatin induced hepatic oxidative stress and apoptotic damage via MAPKs, mitochondria, calpain and caspase12 dependent pathways.
Atorvastatin induces hepatic oxidative stress and apoptosis in mice through MAPKs, mitochondria, and ER dependent pathways, with calcium ions and reactive oxygen species acting as key mediators of apoptosis.
DOI